| 引用本文:代忠1，田立霞1，陶丰娟1，姚克青1，秦子舒2.中医辨证论治联合化疗治疗肺癌的临床研究[J].世界中医药,2017,(07):. |
|
| 中医辨证论治联合化疗治疗肺癌的临床研究 |
| Clinical Study on Treatment of Lung Cancer with TCM Syndrome Differentiation Combined with Chemotherapy |
| 投稿时间：2017-06-10 |
| DOI：10.3969/j.issn.1673-7202.2017.07.021 |
| 中文关键词: 中医辨证论治 化疗 肺癌 |
| English Keywords:TCM syndrome differentiation Chemotherapy Lung cancer |
| 基金项目:国家中医药重点专科建设项目（ZJ0901ZL020） |
|
| 摘要点击次数: 1314 |
| 全文下载次数: 922 |
| 中文摘要: |
| 目的：研究中医辨证论治联合化疗对肺癌近期疗效以及生命质量的影响，分析该治疗方式的价值。方法：随机选取2011年至2014年1月期间来我院进行治疗的肺癌患者90例，并分为2组，观察组使用中医辨证论治联合化疗，对照组使用单纯化疗，经过2个疗程的治疗后比较2组患者的近期疗效，并对治疗前后生命质量差异进行评价。结果：观察组治疗总有效率为93.33%，CR9例（20.00%）、PR33例（73.33%），这3项均高于对照组，对照组分别为77.78%、15.56%和62.22%，P<0.05；观察组的1年生存率、2年生存率和3年生存率分别为68.89%、37.78%和17.78%均明显高于对照组的46.67%、24.44%、11.11%，P<0.05；观察组的平均中位生存期为（18.2±5.1）个月也明显多于对照组的（13.0±3.7）个月，P<0.05，观察组总不良反应更小；治疗后观察组的生理情况、社会家庭情况、情感、功能和肺癌症状评分分别为（19.3±3.5）、（20.5±3.1）、（17.6±2.8）、（19.0±3.7）和（25.0±4.7）远远大于对照组，P<0.05。结论：中医辨证论治联合化疗是治疗肺癌的有效方案，较单一化疗大大提高了患者的生存期，并有效缓解疼痛提高生命质量。 |
| English Summary: |
| To study the effect of traditional Chinese medicine syndrome differentiation combining with chemotherapy on the recent curative effect of lung cancer as well as quality of life of lung cancer patients, and to evaluate this treatment.Methods:A total of 90 patients with lung cancer who were treated in our hospital from January 2011 to January 2014 were randomly divided into two groups. The study group was treated by chemotherapy combined with TCM syndrome differentiation. The control group was treated by chemotherapy only. After two courses of treatment The recent curative effects of the two groups were compared, and the differences in quality of life before and after treatment were evaluated. Results:In study group, the total effective rate was 93.33%, CR was 9 (20.00%) and PR was 33 (73.33%), while the control group was 77.78%, 15.56% and 62.22%, respectively (P<0.05). The 1-year survival rate, 2-year survival rate and 3-year survival rate were 68.89%, 37.78% and 17.78% respectively in the study group,and they were significantly higher than those in the control group(46.67%, 24.44%, 11.11%, P<0.05). The medium survival time was (18.2±5.1) months,which was significantly higher than those in the control group (13.0±3.7 months, P<0.05), the total adverse reactions were lesser in the study group; all kinds of scores of the study group after treatment (the physiological condition scores 19.3±3.5, family condition scores 20.5±3.1, emotion scores 17.6±2.8, function scores 19.0±3.7 and symptom scores 25.0±4.7) were significantly better than those in the control group (P<0.05). Conclusion:Combination of chemotherapy and TCM syndrome differentiation is an effective treatment for lung cancer, which greatly improves the survival time of patients, relieves pain and improves the quality of life of patients. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|
